Rani Therapeutics Holdings Inc - Ordinary Shares Class A Live Stock Price Today, Share Analysis and Chart

Name: Rani Therapeutics Holdings Inc - Ordinary Shares Class A: Is Infosys Ltd. worth buying?
Item: Rani Therapeutics Holdings Inc - Ordinary Shares Class A
Rating: 0.48275
Author: Trendlyne DVM scores

about

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to pain...

0.50 0.04 (8.70%)

86.67% Fall from 52W High

358.2K

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

5.0 / 100

Technically Bearish

14.3 / 100

1Yr Price target upside is 1450%

4 analysts

Rani Therapeutics Holdings... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Rani Therapeutics Holdings Inc - Ordinary Shares Class A Live Stock Price Today, Share Analysis and Chart

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to pain...

86.67% Fall from 52W High

SWOT Analysis

Rani Therapeutics Holdings... Live Price Chart